Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.

Journal of viral hepatitis - 1 Nov 2010

Shaker O, Ahmed A, Doss W, Abdel-Hamid M

Abstract excerpt

The prevalence of hepatitis C virus (HCV) infection varies across the world, with the highest number of infections reported in Egypt. Expression of the MxA gene has been found to be a reliable and sensitive marker for the induction of endogenous type I interferons (IFNs) during viral infections. This study examined the correlation of gene expression of MxA with the response to treatment with pegylated-IFN-alfa2b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Monitoring
Share to Egypt
Share to GTP-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Myxovirus Resistance Proteins

Share to Polyethylene Glycols

Source

Identifiers

PMID: 20002306
DOI: 10.1111/j.1365-2893.2009.01241.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.PMID 20002306Read ↗

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin.Semantic proximity Read ↗

Deciphering the Significance of Plasma Chemokines as Prognostic Biomarkers in Pegylated IFN-Α-2a /Ribavirin-Treated Chronic Hepatitis C Genotype 4 Patients.Semantic proximity Read ↗

Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.Semantic proximity Read ↗

MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.Semantic proximity Read ↗

Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.Semantic proximity Read ↗

MONOCYTE CHEMOTACTIC PROTEIN AND RESPONSE TO PEGYLATED INTERFERON-ALPHA-2A TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) GENOTYPE 4.Semantic proximity Read ↗

MxA and PKR expression in chronic hepatitis C.Semantic proximity Read ↗

Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.Semantic proximity Read ↗

Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.Semantic proximity Read ↗

Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.Semantic proximity Read ↗

MicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patients.Semantic proximity Read ↗

MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.